NXT2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.731390E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.248970E-01
Normal-vs-Stage2
2.299800E-01
Normal-vs-Stage3
1.140910E-03
Normal-vs-Stage4
7.587400E-01
Stage1-vs-Stage2
6.884200E-01
Stage1-vs-Stage3
2.522400E-01
Stage1-vs-Stage4
4.003200E-01
Stage2-vs-Stage3
3.042900E-03
Stage2-vs-Stage4
3.975000E-01
Stage3-vs-Stage4
2.020600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.489360E-01
Normal-vs-AfricanAmerican
2.029000E-01
Normal-vs-Asian
4.660600E-01
Caucasian-vs-AfricanAmerican
6.540400E-01
Caucasian-vs-Asian
7.054600E-01
AfricanAmerican-vs-Asian
9.885600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.262960E-01
Normal-vs-Female
2.549600E-01
Male-vs-Female
1.862450E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.555900E-02
Normal-vs-Age(41-60Yrs)
3.731400E-01
Normal-vs-Age(61-80Yrs)
1.354960E-01
Normal-vs-Age(81-100Yrs)
1.115680E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.146600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.286400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.799200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.108100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.660400E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.721800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.631390E-01
Normal-vs-Daily Drinker
9.608300E-02
Normal-vs-Weekly Drinker
1.553810E-01
Normal-vs-Occasional Drinker
2.526200E-01
Normal-vs-Social Drinker
6.942300E-02
Non Drinker-vs-Daily Drinker
7.682200E-01
Non Drinker-vs-Weekly Drinker
9.519400E-01
Non Drinker-vs-Occasional Drinker
5.231000E-01
Non Drinker-vs-Social Drinker
7.926600E-01
Daily Drinker-vs-Weekly Drinker
8.485600E-01
Daily Drinker-vs-Occasional Drinker
3.605200E-01
Daily Drinker-vs-Social Drinker
5.684400E-01
Weekly Drinker-vs-Occasional Drinker
5.420000E-01
Weekly Drinker-vs-Social Drinker
7.563600E-01
Occasional Drinker-vs-Social Drinker
6.964400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.696200E-01
Normal-vs-Grade 2
8.661000E-01
Normal-vs-Grade 3
9.502000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.281700E-02
Grade 1-vs-Grade 3
1.575960E-02
Grade 1-vs-Grade 4
7.696200E-01
Grade 2-vs-Grade 3
1.473030E-01
Grade 2-vs-Grade 4
8.661000E-01
Grade 3-vs-Grade 4
9.502000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.146100E-02
Normal-vs-NonDiabetic
1.034570E-01
Diabetic-vs-NonDiabetic
4.804400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.696120E-02
Normal-vs-NoPancreatitis
1.027420E-01
Pancreatitis-vs-NoPancreatitis
4.248800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.407700E-02
Normal-vs-N1
2.841800E-01
N0-vs-N1
1.175510E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.423000E-01
Normal-vs-TP53-NonMutant
8.340200E-02
TP53-Mutant-vs-TP53-NonMutant
1.137510E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
